Bromantane
BROMActoprotector studied in fatigue and cognition.
Also known as: Ladasten, ADK-709
Overview
Bromantane is an actoprotector studied in fatigue-resistance, cognition, and physical-performance research, noted for combining stimulant and anxiolytic-like profiles.
An 'actoprotector' (anti-fatigue) compound developed in Russia, unusual for combining mild stimulant and anxiolytic effects. Research suggests it enhances dopamine synthesis by upregulating tyrosine hydroxylase, improving endurance and mental performance under stress without typical stimulant crash.
Studied for upregulating dopamine biosynthesis enzymes (tyrosine hydroxylase), supporting sustained dopaminergic signaling.
Molecular information
An adamantane compound; not a peptide. Acts partly via dopamine-synthesis gene regulation.
Pharmacokinetics
Illustrative relative-concentration model derived from published pharmacokinetic research. Curve is normalized and provided for educational comparison only — not a dosing schedule.
Research applications
- Fatigue-resistance research
- Cognitive-performance studies
- Dopaminergic-signaling investigations
Research protocols
Protocols summarized from published research models. Provided for scientific reference only — not dosing guidance for human use.
Observed effects timeline
Aggregated observations reported across research literature. Timing and magnitude vary by model and are not a guarantee of outcome.
Acute
Anti-fatigue and mild stimulant effects reported within a few hours.
Week 1–3
Endurance and stress-resilience changes reported; tolerance is low in research.
Research compatibility
Describes how compounds are studied alongside one another in the literature. Not a recommendation to co-administer.
Semax
Complementary focus/energy nootropic pathways.
Selank
Energy plus anxiolytic balance studied together.
Stimulants
Additive dopaminergic/stimulant effects — monitor.
Quality indicators
Consistent oral form
Research material is typically a capsule or tablet; verify labeled concentration.
Dry storage
As a stable small molecule, it does not require cold-chain handling.
Slight clumping
Small clumps that dissolve completely with gentle swirling are acceptable — shipping can cause minor compaction.
Collapsed or melted appearance
Powder that looks collapsed, melted, or stuck to the vial walls may have been exposed to heat in transit.
Cloudy after reconstitution
Persistent cloudiness, particles, or precipitate after gentle mixing can indicate a degraded or contaminated peptide.
Reported observations & safety
Safety signals reported in the research literature. Compiled for scientific awareness — not medical advice.
- Generally reported as well tolerated with low dependence potential in the research literature.
- Most evidence originates from Russian research and is less replicated elsewhere; it is a doping-banned substance in sport.
References & further reading
Bromantane: actoprotector and dopaminergic effects (review)
Review of bromantane's combined stimulant/anxiolytic profile and dopamine-synthesis upregulation.
View studyTopics
This entry is provided for educational and informational purposes only. It is not medical advice, a dosing protocol, or a claim of therapeutic benefit. Research compounds are supplied strictly for laboratory and research use — not for human or veterinary consumption.
Substantial peer-reviewed research across multiple models.
This compound is part of our educational reference and is not currently stocked. Browse the catalogue for available research-grade peptides.
Browse catalogue